UCERIS 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA
September 15, 2014 at 17:32 PM EDT
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that the FDA has granted tentative approval for UCERIS(R) (budesonide) ...